Letter to the editor: Comment on "Cardiometabolic benefits of Lacticaseibacillus paracasei 8700:2: A randomized double-blind placebo-controlled trial"

Clin Nutr. 2024 Jan;43(1):302-303. doi: 10.1016/j.clnu.2023.11.017. Epub 2023 Nov 15.

Authors

Linghui Tao¹, Zhangchenyang Wang¹, Jinhan Chen¹, Mingxian Chen²

Affiliations

¹ Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang Province, China.
² Department of Gastroenterology, Tongde Hospital of Zhejiang Province, Street Gucui No.234, Region Xihu, Hangzhou 310012, Zhejiang Province, China. Electronic address: chenmingxian2005@126.com.

PMID: 37993388
DOI: 10.1016/j.clnu.2023.11.017

No abstract available

Keywords: Cardiometabolic; Diet; Fiber intake; Gut microbiota; Tea.

Publication types

Letter
Comment

MeSH terms

Cardiovascular Diseases*
Double-Blind Method
Humans
Lacticaseibacillus paracasei*
Probiotics* / therapeutic use
Randomized Controlled Trials as Topic